SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-016404
Filing Date
2020-07-01
Accepted
2020-07-01 06:14:09
Documents
3
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K ea123674-6k_biondvax.htm 6-K 9988
2 PRESS RELEASE DATED JUNE 30, 2020 ea123674ex99-1_biondvax.htm EX-99.1 58970
3 GRAPHIC image_002.jpg GRAPHIC 5576
  Complete submission text file 0001213900-20-016404.txt   77765
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 201003928
SIC: 2836 Biological Products, (No Diagnostic Substances)